• 1. Department of Thoracic Surgery, Shanghai Shidong Hospital, Shanghai, 200438, P.R.China;
  • 2. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200433, P.R.China;
JIANG Gening, Email: jgnwp@aliyun.com
Export PDF Favorites Scan Get Citation

The postpericardiotomy syndrome (PPS) is an inflammation of the pericardium or pleura following a variety of pericardial injuries. The potential pathogenic factors of the PPS are autoimmune, special virus and latent virus infection. PPS is self-limited, but may lead to prolonged hospital stay, readmissions, and need for invasive interventions. The therapy for PSS is mainly empiric anti-inflammatory therapy. The perioperative use of colchicine could reduce the incidence of PPS but is not effective for postoperative atrial fibrillation or postoperative pericardial/pleural effusion. This article mainly analyzes the incidence, risk factors, clinical features, diagnosis and treatment standards, preventive measures and prognosis of PPS.

Citation: ZHOU Qi, XIE Dong, FEI Ke, JIANG Gening. Advancements in diagnosis and treatment of postpericardiotomy syndrome. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2017, 24(4): 306-309. doi: 10.7507/1007-4848.201509049 Copy

  • Previous Article

    The progress of extracorporeal cardiopulmonary resuscitation
  • Next Article

    Clinical value and status of six-minute walk test in thoracic surgery